Dr. Callaghan completed his medical degree and neurology residency at the University of Pennsylvania. He completed a fellowship in neuromuscular disease at the University of Michigan. He also completed a master's degree program in clinical research at the University of Michigan School of Public health.
Areas of Interest
Research: Epidemiology of neuropathy, and health services research of neurologic diseases.
Peripheral neuropathy and neuromuscular disease.
Breaking Free of Opioids
A neurologist shares alternative treatments for chronic pain and the importance of steering clear of opioids.
Should Gabapentin Be a Controlled Substance?
Some neurologists contend the effort to classify gabapentin as a Federal Schedule V Controlled Substance is misguided and note that it could create barriers to care for patients with neuropathic pain.
New Guideline Urges Ditching Opioids for Painful Diabetic Neuropathy
Neurology experts reviewed the latest evidence to offer new recommendations for management of painful neuropathy in diabetes patients.
How Cost-Effective Are New Drugs for Myasthenia Gravis? An ICER Review Weighs the Options
A new analysis from the Institute for Clinical and Economic Review said the evidence available to date shows moderate effectiveness of two newer drugs for myasthenia gravis—eculizumab and efgartigimod—but found their price exceedingly high and their use not cost-effective.
Tingling, Burning in Your Feet? Common Condition May Be the Cause
The number of people experiencing numbness, pins and needles, and burning pain in their feet and toes seems to be on the rise, new research suggests, and some of these folks may be at increased risk for heart trouble.
Medical School or Training
- University of Pennsylvania School of Medicine, 2004
- University of Pennsylvania Hospital, Neurology, PA, 2008
- Neurophysiology, University of Michigan Health System, 2009
- Electrodiagnostic Medicine